Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb

Wollenberg, A; Howell, MD; Guttman-Yassky, E; Silverberg, JI; Kell, C; Ranade, K; Moate, R; van der Merwe, R

Wollenberg, A (reprint author), Ludwig Maximillian Univ, Frauenlobstr 9-11, D-80337 Munich, Germany.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019; 143 (1): 135

Abstract

Background: IL-13 has an important role in atopic dermatitis (AD) pathogenesis. Tralokinumab is a fully human mAb that potently and specifically neutr......

Full Text Link